<SEC-DOCUMENT>0001868279-22-000002-index.html : 20221229
<SEC-HEADER>0001868279-22-000002.hdr.sgml : 20221229
<ACCEPTANCE-DATETIME>20221229113951
ACCESSION NUMBER:		0001868279-22-000002
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		<ITEMS>06b
FILED AS OF DATE:		20221229
DATE AS OF CHANGE:		20221229
EFFECTIVENESS DATE:		20221229

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ArriVent Biopharma, Inc.
		CENTRAL INDEX KEY:			0001868279
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-469072
		FILM NUMBER:		221497473

	BUSINESS ADDRESS:	
		STREET 1:		18 CAMPUS BLVD.
		STREET 2:		SUITE 100
		CITY:			NEWTOWN SQUARE
		STATE:			PA
		ZIP:			19073-3269
		BUSINESS PHONE:		240-780-6356

	MAIL ADDRESS:	
		STREET 1:		18 CAMPUS BLVD.
		STREET 2:		SUITE 100
		CITY:			NEWTOWN SQUARE
		STATE:			PA
		ZIP:			19073-3269
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>